Is Fasenra effective in asthma and wheezing issues?

Hi,

Thanks for reaching out with iCliniq.

I read your query and understand your concern.

Indeed, Fasenra (Benralizumab) is an FDA-approved biologic medication for the treatment of severe asthma in individuals aged 12 years and older. It targets interleukin-5 (IL-5), a protein involved in the inflammatory process contributing to asthma symptoms. Studies have demonstrated the effectiveness of Fasenra in treating severe asthma, particularly in individuals experiencing symptoms despite using standard medications. Clinical trials show significant reductions in asthma exacerbations, improved lung function, and a decreased need for oral corticosteroids. For teenage girls with severe asthma, Fasenra may bring several positive outcomes:

1. Improved asthma control:

Fasenra's action on IL-5 reduces airway inflammation, leading to improved asthma control and fewer symptoms like wheezing and shortness of breath.

2. Reduced need for oral corticosteroids:

By enhancing asthma control, Fasenra may decrease reliance on oral corticosteroids, minimizing associated side effects such as weight gain and mood changes.

3. Improved quality of life:

- Severe asthma can impact daily life significantly. Fasenra's ability to enhance asthma control and reduce exacerbations may improve a teenage girl's overall quality of life, enabling fuller participation in daily activities.

While Fasenra offers these benefits, it is crucial to note potential side effects, including allergic reactions, injection site reactions, and eosinophilia. Starting this medication should be done under the supervision of your doctor to monitor its effects.

Looking forward to your response in order to help you.

Thank you.